Psychosocial Oncology and Patient-Centered Preventive Strategies
Integrating psychosocial considerations into preventive oncology is essential for improving patient engagement, adherence, and overall outcomes. Psychological factors such as anxiety, perceived risk, health beliefs, and social support influence individuals’ participation in screening programs, adherence to preventive therapies, and responsiveness to lifestyle interventions. Understanding these behavioral determinants allows clinicians and public health professionals to design personalized, patient-centered strategies that encourage proactive participation in cancer prevention initiatives. Interventions include structured counseling, motivational interviewing, cognitive-behavioral approaches, and peer-support networks aimed at enhancing health literacy and informed decision-making. The session examines strategies for managing distress related to genetic testing, biomarker results, or incidental findings from multi-modal screening, emphasizing ethical communication, shared decision-making, and informed consent. Socioeconomic and cultural factors that contribute to disparities in preventive oncology uptake are addressed, with a focus on tailoring interventions for diverse populations and underserved communities. Technology-assisted psychosocial support, including tele-counseling, mobile apps, and digital communities, is increasingly being used to extend access to mental health and educational resources in real-time. The integration of psychosocial assessment tools into clinical workflows enables continuous monitoring of patient well-being and adherence, facilitating adaptive interventions. By combining behavioral science, community engagement, and patient-centered care models, this session highlights how preventive oncology can move beyond technical diagnostics to address the holistic needs of patients, improve participation in early detection programs, and ultimately enhance long-term health outcomes and quality of life.